Study of sudapyridine in healthy Chinese men
Part of Infections clinical trials.
This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 18 and 45 years old.
- Your body mass index (BMI) must be between 19 and 26, and you must weigh at least 110 pounds (50 kg).
- You have no major medical conditions, such as heart disease, liver problems, or infections like hepatitis or HIV.
- You have not taken any prescription or over-the-counter medications, herbs, or supplements in the past 2 weeks.
- You have no history of stomach or intestinal surgery that could affect drug absorption.
- You are willing to follow the study schedule and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This study tests how the body processes the experimental drug HPP737 in healthy Chinese men. It helps researchers understand how the drug is absorbed, broken down, and eliminated.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This trial tests a new drug called IPG1094 in healthy people to see if it's safe and how the body handles it. Healthy volunteers may join to help find the right dose for future studies.
This study tests how a new drug called HDM1002 leaves the body, using a tiny amount of a radioactive marker. It's for healthy men, and the results will help researchers understand how the drug works.
Hear when a new TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.